Repligen Stock Outlook: Risk Skewed To The Downside Through 2026

Repligen (NASDAQ:RGEN) has been in a steady downtrend for over 1400 days. Adhishthana principles suggest the weakness is likely to continue. Here’s a breakdown of the stock’s current structure.

Read the full article on Benzinga for deeper insights into the Adhishthana Cycle, the stock’s recent trajectory, and expert commentary.